Literature DB >> 18028503

Differential suppression of dendritic cell cytokine production by anti-inflammatory drugs.

M J Toebak1, J de Rooij, H Moed, T J Stoof, B M E von Blomberg, D P Bruynzeel, R J Scheper, S Gibbs, T Rustemeyer.   

Abstract

BACKGROUND: Various anti-inflammatory drugs are available for the treatment of skin disorders. In these diseases, untoward immune responses to endogenous and/or environmental antigens are initiated by maturation and polarization of dendritic cells (DC).
OBJECTIVE: To explore the suppressive effects of anti-inflammatory drugs on DC maturation and, in particular, polarization.
METHODS: Exposure of DC to nickel in vitro results in DC maturation and secretion of both type 1 and type 2 cytokines, thereby providing a model to study the effects of anti-inflammatory drugs on DC responses. The inhibitory effects of anti-inflammatory drugs (ciclosporin, dexamethasone, diclofenac, dimethylfumarate, hydrocortisone, lactoferrin, 1-alpha,25-dihydroxyvitamin D3) on DC maturation (CD83, CD86, HLA-DR, CXCL8) and polarization (type 1: IL-12p70, TNF-alpha; type 2: IL-10, CCL17) were studied.
RESULTS: All anti-inflammatory drugs, except for lactoferrin, had inhibitory effects on DC maturation. Hydrocortisone and dexamethasone exclusively suppressed the release of type 1 cytokines. A less pronounced, but similar profile was observed for dimethylfumarate and 1-alpha,25-dihydroxyvitamin D3. Ciclosporin suppressed both type 1 and 2 cytokines. In contrast, diclofenac suppressed only type 2 DC cytokine secretion.
CONCLUSION: The present results give more insight into the pharmacological effects of immunosuppressive drugs on the immune system, and can thereby contribute to a more rational selection of anti-inflammatory drugs for the treatment of inflammatory skin disorders.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18028503     DOI: 10.1111/j.1365-2133.2007.08297.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  8 in total

Review 1.  The emerging role of peptides and lipids as antimicrobial epidermal barriers and modulators of local inflammation.

Authors:  N K Brogden; L Mehalick; C L Fischer; P W Wertz; K A Brogden
Journal:  Skin Pharmacol Physiol       Date:  2012-04-26       Impact factor: 3.479

2.  The selective COX-2 inhibitor Etoricoxib reduces acute inflammatory markers in a model of neurogenic laryngitis but loses its efficacy with prolonged treatment.

Authors:  Manuel Lima-Rodrigues; Nuno Lamas; Ana Valle-Fernandes; Andrea Cruz; Artur Vieira; Pedro Oliveira; Jorge Pedrosa; António G Castro; Rui M Reis; Fátima Baltazar; Armando Almeida
Journal:  Inflamm Res       Date:  2010-03-28       Impact factor: 4.575

Review 3.  Immunomodulatory effects of lactoferrin.

Authors:  Tania Siqueiros-Cendón; Sigifredo Arévalo-Gallegos; Blanca Flor Iglesias-Figueroa; Isui Abril García-Montoya; José Salazar-Martínez; Quintín Rascón-Cruz
Journal:  Acta Pharmacol Sin       Date:  2014-05       Impact factor: 6.150

Review 4.  Lactoferrin as a natural immune modulator.

Authors:  Jeffrey K Actor; Shen-An Hwang; Marian L Kruzel
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

5.  Diclofenac enables unprecedented week-long microneedle-enhanced delivery of a skin impermeable medication in humans.

Authors:  Nicole K Brogden; Stan L Banks; Leslie J Crofford; Audra L Stinchcomb
Journal:  Pharm Res       Date:  2013-06-13       Impact factor: 4.200

6.  Diclofenac Inhibits 27-hydroxycholesterol-induced Differentiation of Monocytic Cells into Mature Dendritic Cells.

Authors:  Yonghae Son; Bo-Young Kim; Young Chul Park; Koanhoi Kim
Journal:  Immune Netw       Date:  2017-06-20       Impact factor: 6.303

7.  NSAIDs affect dendritic cell cytokine production.

Authors:  Tonke K Raaijmakers; Renske J E van den Bijgaart; Gert Jan Scheffer; Marleen Ansems; Gosse J Adema
Journal:  PLoS One       Date:  2022-10-13       Impact factor: 3.752

8.  Effects of Jaw Periosteal Cells on Dendritic Cell Maturation.

Authors:  Jingtao Dai; Daniela Rottau; Franziska Kohler; Siegmar Reinert; Dorothea Alexander
Journal:  J Clin Med       Date:  2018-09-29       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.